Yashoda Hospitals, one of South India’s largest private healthcare providers, has opened a specialised AI-Enabled Early Cancer Detection Clinic at its Secunderabad flagship facility. The clinic, inaugurated on January 24, 2026, aims to shift cancer care upstream by identifying tumours at the earliest possible stage when they are most treatable and often curable using a combination of advanced imaging, molecular diagnostics, and artificial intelligence.

The clinic’s core offering is a multi-modal screening programme tailored to individual risk profiles. Patients undergo a comprehensive assessment that includes:

AI-enhanced interpretation of low-dose CT for lung cancer, mammography and breast MRI for breast cancer, and endoscopic imaging for gastrointestinal malignancies

Liquid biopsy panels that detect circulating tumour DNA and other cancer-specific biomarkers

Genetic and polygenic risk scoring for hereditary cancers (breast, ovarian, colorectal, pancreatic)

AI-driven risk stratification that analyses lifestyle factors, family history, and previous screening data to personalise follow-up intervals and test selection

The AI algorithms, developed in-house and in collaboration with academic partners, have been trained on a large Indian patient dataset to recognise patterns specific to local epidemiology such as higher prevalence of oral, cervical, and gall bladder cancers. Early internal data from the pilot phase indicates the clinic is detecting stage 0–I cancers at a rate 2–3 times higher than traditional screening approaches in similar populations, with significantly fewer false positives than standalone imaging or biomarker tests.

Dr. G.S.K. Sharma, Director of Medical Services at Yashoda Hospitals, explained the clinic’s mission: “Cancer outcomes improve dramatically when detected early, yet most cases in India are still diagnosed at advanced stages. Our AI-enabled clinic brings together the best of imaging, molecular diagnostics, and intelligent risk assessment to catch cancers when they are small and localised giving patients the best possible chance of cure with minimal intervention.”

The clinic operates on a package-based model with tiered pricing to improve accessibility, including subsidised screening for economically weaker sections through CSR and government tie-ups. It also integrates with Yashoda’s broader oncology network, ensuring seamless transition to treatment planning, surgery, chemotherapy, or radiation as needed.

The launch aligns with national priorities under the National Cancer Control Programme and Ayushman Bharat, which increasingly emphasise prevention and early detection. Yashoda plans to replicate the AI-enabled clinic model at its other facilities in Secunderabad, Somajiguda, and Malakpet, while exploring partnerships to extend the technology to smaller hospitals and rural screening camps.